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YeastRNAi is a highly conserved mechanism in almost every eukaryote with a few exceptions including the model
organism Saccharomyces cerevisiae. A recent study showed that the introduction of the two core components
of canonical RNAi systems, Argonaute and Dicer, from another budding yeast, Saccharomyces castellii, restores
RNAi in S. cerevisiae. We report here that a functional RNAi system can be reconstituted in yeast with the in-
troduction of only S. castellii Dicer and human Argonaute2. Interestingly, whether or not TRBP2 was present,
human Dicer was unable to restore RNAi with either S. castellii or human Argonaute. Contrary to previous re-
ports, we ﬁnd that human Dicer, TRBP2 and Argonaute2 are not sufﬁcient to reconstitute RNAi in yeast when
bona ﬁde RNAi precursors are co-expressed. We and others have previously reported that Hsp90 regulates
conformational changes in human and Drosophila Argonautes required to accommodate the loading of
dsRNA duplexes. Here we show that the activities of both human and S. castellii Argonaute are subject to
Hsp90 regulation in S. cerevisiae. In summary, our results suggest that regulation of the RNAi machinery by
Hsp90 may have evolved at the same time as ancestral RNAi.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
RNA interference (RNAi) regulates gene expression at both the
transcriptional and post-transcriptional levels in eukaryotes [1,2].
Long double-stranded RNA (dsRNA) precursors undergo one or
more processing steps to generate small interfering RNAs (siRNAs)
or microRNAs (miRNAs) that are ultimately incorporated into the
RNA-induced silencing complex (RISC). RNaseIII proteins speciﬁcally
cleave dsRNA and include multiple components of the RNAi pathway
[3]. In the miRNA biogenesis pathway, primary miRNA transcripts are
processed in the nucleus by the class 2 RNaseIII proteins Drosha and
Pasha, into hairpin structures [4,5]. This step is critical to generate
2 nt 3′ overhangs at the ends of hairpins that can be recognized
by the PAZ domain of the class 3 RNaseIII protein, Dicer, which then
cleaves the double-stranded portion of the hairpin into 21–23
nucleotide dsRNAs [6–10]. Canonical Dicer proteins have been called
“molecular rulers” for their ability to cleave dsRNA a ﬁxed distance
from the end [7]. The short dsRNAs generated by Dicer bind to a
core component of RISC called Argonaute which, depending on the
properties of the Argonaute isoform involved, cleaves or displacesuorescent protein; TRBP2, Tar
te).
rights reserved.the passenger strand [11–15]. This leaves the ssRNA guide strand in
the binding cleft of Argonaute and comprises the functional core of
the RISC. It is this ssRNA-containing Argonaute complex that targets
mRNAs for cleavage or translational suppression. Despite signiﬁcant
advances in our understanding of the RNAi system, the minimum re-
quirements for the pathway and how it is regulated are not fully
understood.
It is estimated that ~70% ofmammalian genes are regulated byRNAi,
but not all eukaryotes possess an RNAi system [16–18]. The budding
yeast Saccharomyces cerevisiae is a powerful model organism that has
been widely used in genetic and molecular studies of eukaryotic cells,
however, it lacks any recognizable homologues of Argonaute or Dicer,
and does not carry out RNAi-mediated silencing [18]. Recent studies
show that some closely related species of budding yeasts such as
Saccharomyces castellii and Kluyveromyces polysporus, are capable of
RNAi-mediated silencing [19]. The Argonaute proteins in these fungi
share all four identiﬁed domains with human Argonaute but also have
elongated N-terminal regions, whereas S. castellii Dicer is much shorter
than canonical Dicer proteins from humans and the ﬁssion yeast
Schizosaccharomyces pombe (Fig. 1A and B). RNAi can be restored in
S. cerevisiae by introducing only Argonaute and Dicer from either
S. castellii or K. polysporus [19,20]. The reconstituted RNAi system si-
lences both exogenous reporter genes and endogenous retrotransposons.
This suggests that the last common ancestor of these budding yeasts pos-
sessed RNAi, but it was lost in some species including S. cerevisiae. The
RNAi pathway in humans is more complicated but three components,
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Fig. 1. Domain architecture of Dicer and Argonaute proteins. A. Dicer proteins structure with helicase (light green), dsRNA binding (orange), PAZ (red), and RNaseIII (blue) domains
in ribbon representation. B. Argonaute protein structure with N (purple), PAZ (red), Middle (orange), and PIWI (green) domains in ribbon representation. The amino acid sequence
of Argonaute and Dicer proteins was retrieved from GenBank, and the domain boundaries predicted by SMART [41,42] and UniProt (http://www.uniprot.org/).
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stitute the minimal human RISC complex in vitro [21].
The important role that the RNAi system plays in regulating gene
expression necessitates that RNAi itself is subject to regulation.
Clues about the regulation of the RNAi machinery have come from
the observation that the loading of dsRNA duplexes into human and
Drosophila Argonaute is ATP-dependent [23]. Moreover, it has been
shown that the hydrolysis of ATP is catalyzed by the Hsc70/Hsp90
chaperone machinery during formation of the RISC [23–25]. We and
others have proposed that Hsp90 facilitates a conformational change
required to accommodate the RNA duplex into the binding cleft of
Argonaute. Importantly, the components of the Hsp90 system are
highly conserved in eukaryotes and many human Hsp90 client pro-
teins can be regulated by the yeast Hsp90 system [26,27]. Only
recently has the Hsp90 system been identiﬁed as a key regulator
of the RNAi system in higher eukaryotes. It is not clear however
if Hsp90 plays a role in the regulation of distantly related RNAi
systems — such as that from S. castellii.
We report here that RNAi can be reconstituted in S. cerevisiaewith
S. castellii Dicer and either S. castellii Ago1 or human Argonaute2. Con-
trary to a recently published study however, we observed that human
Dicer did not support functional RNAi with either Argonaute protein,
with or without the co-factor TRBP2. Similar to RNAi in humans and
Drosophila, we found that Hsp90 plays an important regulatory role
in reconstituted RNAi systems in budding yeast; consistent with the
structural conservation of Argonaute proteins.
2. Materials and methods
2.1. Plasmids and strains
Silencing constructs were expressed from plasmids pRS403-
PGAL1-weakSC-GFP, pRS403-PGAL1-strongSC-GFP and pRS403-PGAL1-hpSC-URA3 as previously described [19]. Untagged versions of
S. castelli Argonaute and Dicer were encoded by pRS404-PTEF-ScaAgo1
and pRS405-PTEF-ScaDcr1 (both acquired from Addgene) as previously
described [19].
We constructed the pRS406-PADH1-GFP(S65T) dual reporter plas-
mid (for uracil autotrophy and GFP ﬂuorescence) as follows. The
SacI–KpnI restriction fragment from p414ADH1 [28] was cloned into
similarly digested pRS406 to make pRS406-PADH1. GFP(S65T) was am-
pliﬁed by polymerase chain reaction (PCR) with primers designed to
incorporate an upstream BamHI and downstream SalI sites. This PCR
fragment was cut with BamHI and SalI and cloned into similarly
digested pRS406-PADH1. The resultant reporter plasmid was used to
measure both URA3 and GFP expression in our studies.
The complete human Ago2 coding sequence was ampliﬁed by PCR
with SpeI (upstream) and SalI (downstream) sites and cloned in place
of S. castellii Ago1 in pRS404-PTEF-ScaAgo1 (digested with SpeI and
XhoI) to make pRS404-PTEF-hAgo2.
The complete human Dicer coding sequence was ampliﬁed by PCR
with SpeI (upstream) and XhoI (downstream) sites and cloned in
place of S. castellii Ago1 in pRS405-PTEF-ScaDcr1 (digested with XbaI
and XhoI) to make pRS405-PTEF-hDcr1.
pRS401-PTEF-TRBP2-natNT2 was constructed as follows. The KpnI–
SacI fragment from p414TEF [28] was inserted into the similarly cut
pRS401 to make pRS401PTEF. PCR-ampliﬁed TRBP2 (complete coding
sequence with upstream BamHI and downstream XhoI sites) was
cloned into the BamHI and XhoI sites of pRS401PTEF to make
pRS401-PTEF-TRBP2. Finally, the nourseothricin (natNT2) selectable
marker from pRS41N [29] was ampliﬁed by PCR to have an EagI site
upstream of the promoter and downstream of the terminator. This
fragment was cloned into the EagI site of pRS401-PTEF-TRBP2 to
make pRS401-PTEF-TRBP2-natNT2.
Epitope tagging of Ago and Dcr was done as follows. For human
Ago2 and S. castellii Ago1, complementary primers comprised of an
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hangs compatible with SpeI. This small double stranded fragment
was cloned into the SpeI site in pRS404-PTEF-hAgo2 and pRS404-
PTEF-ScaAgo1 and clones with the appropriate orientation were iden-
tiﬁed by sequencing. The resultant plasmids were called pRS404-
PTEF-HA-hAgo2 and pRS404-PTEF-HA-ScaAgo1. For human Dcr1, the
C terminal domain of hDcr1 was ampliﬁed by PCR with a sense
primer complementary to the sequence near an internal SacII site
(5′-gagagaccgcggcagcactccccgggggtcctg-3′) and an antisense primer
complementary to the hDcr1 C-terminus and harboring the myc
coding sequence and a XhoI site (5′-gagactcgagctatcacagatcttcttca
gaaataagtttttgttcttgggaacctgagg-3′). This fragment was cloned into
the SacII and XhoI sites of pRS405-PTEF-hDcr1 to make pRS405-
PTEF-hDcr1-myc. For S. castellii Dcr1, the C terminal domain of ScaDcr1
was ampliﬁed by PCR with a sense primer complementary to the
sequence near an internal NheI site (5′-gagagagctagcaacatccccagt
ctcagtc-3′) and an antisense primer complementary to the ScaDcr1
C-terminus and harboring the myc coding sequence and a XhoI
site (5′-gagactcgagctatcacagatcttcttcagaaataagtttttgttccagattgttgc-3′).Table 1
Yeast strains used in this study.
Strain Genotype
W303a MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15
YW1 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS406-PADH
YW2 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS406-PADH
YW3 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW4 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW5 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-SC-URA3
YW6 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW7 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW8 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-SC-URA3
YW9 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW10 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW11 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-SC-URA3
YW12 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW13 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW14 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-SC-URA3
YW15 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW16 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW17 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-SC-URA3
YW18 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW19 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T)
YW20 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T) pRS403-PGAL1-SC-URA3
YW21 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
YW22 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T)
YW23 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T) pRS403-PGAL1-SC-URA3
YW24 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-weakSC-GFP
YW25 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
PGAL1-strongSC-GFP
YW26 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-weakSC-GFP
YW27 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-strongSC-GFP
YW28 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-weakSC-GFP
YW29 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS403-PGAL1-strongSC-GFP
YW30 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T) pRS403-PGAL1-weakSC-GFP
YW31 MATa leu2-3,112 trp1-1 can1-100 URA3-1 ade2-1 his3-11,15 pRS404-PTEF
pRS406-PADH1-GFP(S65T) pRS403-PGAL1-strongSC-GFPThis fragment was cloned into the NheI and XhoI sites of pRS405-
PTEF-ScaDcr1 to make pRS405-PTEF-ScaDcr1-myc.
All our strains were constructed fromW303a (MATa ura3-1 leu2-3,
112, trp1-1, his3-11, 15, ade2-1, can1-100). Table 1 summarizes the
genotypes of all strains used. Brieﬂy, each strain was constructed by
integration of different combinations of pRS403, pRS404, pRS405
and pRS406 vectors harboring cloned elements expressed under the
control of TEF1 or ADH1 promoters.
2.2. Flow cytometry analysis of GFP expression
Analysis of GFP ﬂuorescence was carried out as previously de-
scribed [19,21]. Brieﬂy, each strain was inoculated in synthetic com-
plete media with 2% rafﬁnose and grown overnight. Fresh cultures
were then seeded from the overnight cultures (500 uL to 5 mL fresh
media) and cells were grown to log-phase with either 2% glucose
(non-inducing) or 2% galactose (inducing). 0.2 OD600 units of cells
were harvested by centrifugation at 960 ×g for 2 min in a micro-
centrifuge tube. The cell pellet was washed two times with 1 mLReference
[22]
1-GFP(S65T) This study
1-GFP(S65T) pRS403-PGAL1-SC-URA3 This study
-ScaAgo1 pRS405-PTEF-ScaDcr1 This study
-ScaAgo1 pRS405-PTEF-ScaDcr1 pRS406-PADH1-GFP(S65T) This study
-ScaAgo1 pRS405-PTEF-ScaDcr1 pRS406-PADH1-GFP(S65T) This study
-HA-ScaAgo1 pRS405-PTEF-ScaDcr1-myc This study
-HA-ScaAgo1 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-ScaAgo1 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-ScaDcr1-myc This study
-HA-hAgo2 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-ScaAgo1 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-ScaAgo1 pRS405-PTEF-ScaDcr1 pRS406-PADH1-GFP(S65T) This study
-ScaAgo1 pRS405-PTEF-ScaDcr1 pRS406-PADH1-GFP(S65T) pRS403- This study
-HA-ScaAgo1 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-ScaAgo1 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-ScaDcr1-myc pRS406-PADH1-GFP(S65T) This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
-HA-hAgo2 pRS405-PTEF-hDcr1-myc pRS401-PTEF-TRBP2-natNT2 This study
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using the 488 nm laser on a FACSCalibur (BD Biosciences). Data were
processed with CellQuest Pro (BD Biosciences) and FlowJo (Tree Star).
2.3. Growth assays
Each strain was grown in synthetic complete media with 2% rafﬁ-
nose overnight. Cells were diluted to OD600 of 1.0, and 1:10 serial dilu-
tions were spotted onto the appropriate plates (SC, SC-ura, or 5-FOA;
containing 2% glucose or galactose) and grown at 30 °C for 3 days.
2.4. Lysate generation and western blotting
Cell lysates were generated as previously described [30]. Protein
lysates were separated by SDS-PAGE and transferred to nitrocellulose
for immunoblotting. Myc-tagged proteins were detected with mouse
monoclonal antibody 9E10 (Millipore) [31]. HA-tagged proteins were
detected with rat monoclonal antibody 3F10 (Roche). TRBP2 was
detected with mouse monoclonal antibody 1D9 (AbCam). Rabbit an-
tiserum raised against yeast β-actin was a kind gift from Gary Eitzen
(University of Alberta) [30]. Human Ago2 was detected with a rabbit
polyclonal antibody raised against the PAZ domain of human Ago2.Fig. 2. Schematic for silencing constructs directed against GFP and URA3. A. The strong sil
inverted repeats of a GFP fragment and forms a dsRNA hairpin structure. The production
The weak silencing construct directed against GFP (weakSC-GFP) is comprised of two tra
galactose-inducible GAL1 promoter (PGAL1) and the antisense transcript (red) is constituti
scripts anneal to form a dsRNA structure. C. The silencing construct directed against URA3
forms a dsRNA hairpin structure. The production of this construct is driven by the galactos
construct used in a previous study with human Dicer, Argonaute2 and TRBP was a single
structure [21].Human Dicer1 was detected with mouse monoclonal antibody
N167/7 (Millipore).
3. Results
3.1. Argonaute and Dicer from S. castellii reconstitute RNAi in S. cerevisiae
Previous studies showed that introduction of S. castellii Argonaute
(ScaAGO1) and Dicer (ScaDCR1) restores RNAi in S. cerevisiae [19]. To
conﬁrm this result, we integrated plasmids encoding ScaAGO1 and
ScaDCR1 respectively into the S. cerevisiae strain, W303a. A dual-
reporter plasmid, encoding GFP and URA3, as well as plasmids
encoding galactose-inducible silencing constructs against these re-
porter genes were also integrated into W303a. The resultant strains
(harboring different combinations of RNAi components) were used
to measure the efﬁciency of silencing of either GFP using ﬂow cytom-
etry, or URA3 using growth assays (Table 1).
The efﬁciency of GFP silencing was measured by comparing the rel-
ative green ﬂuorescence of yeast grown under non-inducing (glucose)
and inducing (galactose) conditions for two different silencing con-
structs [19]. Expression of the strong GFP Silencing Construct
(strongSC-GFP) results in a single RNA transcript that forms a long hair-
pin structure in which the ds stem region is comprised of two invertedencing construct directed against GFP (strongSC-GFP) is a single transcript harboring
of this construct is driven by the galactose-inducible GAL1 promoter (PGAL1) [19]. B.
nscripts by two convergent promoters. The sense transcript (blue) is driven by the
vely driven from the weaker URA3 promoter (PURA3). These two complementary tran-
(SC-URA3) is a single transcript harboring inverted repeats of a URA3 fragment and
e-inducible GAL1 promoter (PGAL1) and is similar to the strongSC-GFP. D. The silencing
, antisense transcript (red) that anneals directly to the GFP mRNA to form a dsRNA
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(weakSC-GFP) produces a ssRNA that is perfectly complementary to
another transcript driven by the URA3 promoter at the opposite end
(Fig. 2B). These two promoters drive the transcription of the same cas-
sette but in opposite directions which results in the formation of a long
dsRNA (Fig. 2B).
Consistent with previous reports, the S. cerevisiae strain express-
ing both ScaAGO1 and ScaDCR1 exhibited RNAi-mediated silencing
(Fig. 3A) [19]. The GFP ﬂuorescence in yeast expressing ScaAGO1,
ScaDCR1 and GFP was reduced when the expression of the weakSC-
GFP construct was induced in galactose (Fig. 3A—blue line). Also con-
sistent with previous studies, yeast harboring the strongSC-GFP con-
struct did not show any GFP ﬂuorescence regardless of induction
conditions [19]. This suggests that the small amount of transcription
from the GAL1 promoter under repressing conditions (glucose) was
sufﬁcient to completely silence GFP expression. Under non-inducing
conditions, the GFP ﬂuorescence in the strain harboring the weakSC-
GFP (Fig. 3A— blue line) was identical to that of a strain that was iden-
tical in every sense except that it lacked a silencing construct (Fig. 3A—
ﬁlled green plot). When grown in galactose however, induction of the
silencing construct resulted in a signiﬁcant reduction in GFP ﬂuores-
cence (Fig. 3A). In contrast, the strain harboring the strongSC-GFP
construct did not exhibit detectable GFP ﬂuorescence even under
repressing (glucose) conditions, likely due to the fact that the GAL1 pro-
moter is leaky even under glucose conditions [19].
The RNAi-dependent silencing of URA3 was assayed by plating se-
rial dilutions of S. cerevisiae cells on agar plates lacking uracil (-Ura),
or containing uracil but also the anti-metabolite 5-ﬂuoroorotic acid
(5-FOA). The expression of the URA3 gene allows for growth on media
lacking uracil but not on media containing uracil and 5-FOA, which is
converted by the URA3 gene product to the toxic 5-ﬂuorouracil. The si-
lencing construct targeting URA3 (SC-URA3) contains inverted repeats
of a URA3 gene fragment driven by the GAL1 promoter (Fig. 2C) [19].
The single-stranded transcript of the hpSC-URA3 construct forms a hair-
pin structure that is comparable to the strongSC-GFP construct.
The growth of yeast expressing ScaAGO1, ScaDCR1 and URA3 was
reduced on media lacking uracil compared to control (i.e. yeast lack-
ing the SC-URA3 silencing construct) only when the silencing con-
struct was induced with galactose (Fig. 4). Similarly, growth of this100 101 102 103 104
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100 101 102 103 104
100 101 102 103 104
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ﬂuorescence intensity.strain on media containing 5-FOA was improved relative to control
when galactose was present to induce expression of the silencing
construct (Fig. 4). This shows that ScaAGO1 and ScaDCR1 are able to
reduce URA3 expression by RNAi-mediated silencing. Consistent
with previous reports, our assays for both GFP ﬂuorescence and
growth on media lacking uracil showed that ScaAGO1 and ScaDCR1
are able to reconstitute RNAi-mediated silencing of reporter genes
in S. cerevisiae [19,20].
One major obstacle we encountered in the construction of our
strains was the loss of integrated genes during successive rounds of
transformation. This was likely due to the high similarity of the back-
bone of the plasmids we used, which allows for unwanted homolo-
gous recombination that disrupts or discards genes of interest while
leaving the selectable markers intact. Moreover, no commercial anti-
bodies are available for ScaAGO1 or ScaDCR1. To overcome this limi-
tation, we added epitope tags to ScaAGO1 and ScaDCR1 to allow
for the detection of protein expression by western blot. ScaAGO1
was tagged at the N-terminus with the hemaglutinin (HA) tag, and
ScaDCR1 was tagged at the C-terminus with the myc epitope. Impor-
tantly, S. cerevisiae cells expressing the epitope-tagged version of
HA-ScaAGO1 and ScaDCR1-myc were capable of silencing both GFP
(Fig. 3) and URA3 (Fig. 4). This demonstrated that the epitope tags
do not impair the function of ScaAGO1 or ScaDCR1 and allowed us to
verify the expression of these proteins in our experiments (Fig. 5).
3.2. Human Argonaute2 and S. castellii Dicer restore RNAi in S. cerevisiae
While conserved in a functional sense, there are structural differ-
ences in the Dicer homologues between the RNAi systems of yeast
and humans (Fig. 1). To determine the level of compatibility between
components like Argonaute and Dicer, we constructed yeast strains ex-
pressing different cross-species, epitope-tagged pairs of these proteins.
To further characterize the role of TRBP2 in RNAi, we constructed a
series of yeast strains containing different combinations of human or
S. castelli Argonaute and Dicer, with and without TRBP2 (Summarized
in Table 1). Five strains were constructed that express the following
Argonaute–Dicer pairs (with and without TRBP2): (1) HA-HsAgo2,
ScaDCR1-myc; (2) HA-ScaAGO1, HsDcr1-myc; (3) HA-ScaAGO1,
HsDcr1-myc, TRBP2; (4) HA-HsAgo2, HsDcr1-myc; (5) HA-HsAgo2,Relative GFP Fluorescence
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lence GFP and URA3 expression. Interestingly, human Argonaute2
(HA-HsAgo2) and S. castellii Dicer (ScaDCR1-myc) restored RNAi-
mediated silencing of reporter genes in S. cerevisiae (Figs. 3C and 4).
Unlike the Ago–Dicer pair from S. castellii, which completely silenced
GFP expression with the strongSC-GFP construct even in glucose, the
HA-HsAgo2/ScaDCR1-myc pair was less efﬁcient at silencing GFP ex-
pression under these conditions (Fig. 3C). In galactose however, the
HA-HsAgo2/ScaDCR1-myc pair efﬁciently silenced GFP expression
even in strains expressing the weakSC-GFP construct. Unexpectedly,
strains expressing HA-HsAgo2, HsDcr1-myc, and TRBP2, did not exhibit
RNAi activity in the GFP ﬂuorescence assay or the URA3-dependent
growth assays regardless of whether the strongSC-GFP or the weakSC-
GFPwas employed (Figs. 3D and 4). To rule out the possibility that the
epitope tags fused to human HsAgo2 and HsDcr1 interfered with func-
tion, we tested strains expressing untagged versions of these proteins
in theURA3 silencing assay.We veriﬁed the expression of all three com-
ponents by western blot but these proteins were similarly unable to re-
constitute RNAi in yeast (Supplemental Fig. 1). These data contrast with
a previous study [21] which reported that expression of these human
RNAi components rendered budding yeast RNAi-competent.WB: α-TRBP2
WB: α-actin 
100 kDa- 
35 kDa- 
55 kDa- 
Fig. 5. The detection of Argonaute, Dicer, and TRBP2 proteins by western blot. Anti-HA,
anti-myc, anti-TRBP2, and anti-S. cerevisiae β-actin antibodies were used to detect pro-
tein expression in yeast lysates. Strains analyzed are indicated above each lane.3.3. Human and S. castellii Argonaute proteins are subject to Hsp90
regulation
Previous work in our lab and others showed that the molecular
chaperone Hsp90, regulates conformational changes in Argonaute re-
quired to accommodate the loading of dsRNA duplexes [23–25].
There are two Hsp90 homologues in S. cerevisiae, the constitutively
expressed HSC82 and the inducible HSP82, which each share high
identity with their mammalian counterparts. Importantly, human
Hsp90 client proteins can be processed in vivo by the yeast Hsp90
2679Y. Wang et al. / Biochimica et Biophysica Acta 1833 (2013) 2673–2681system. We therefore questioned whether the functions of human
and S. castellii Argonautes in the reconstituted RNAi pathways
were regulated by Hsp90. To determine this, we employed the
URA3-dependent growth assay in the presence of the potent Hsp90
inhibitor, radicicol [32]. Under conditions where silencing constructs
were expressed, strains expressing S. castellii Dicer and either
human or S. castellii Argonaute showed reduced silencing of URA3
(i.e. increased growth relative to control strain lacking a silencing
construct) when grown on plates lacking uracil but supplemented
with radicicol (Fig. 6). This suggests that Hsp90 regulates both
human and S. castellii Argonaute function in RNAi.4. Discussion
Since the discovery of RNAi, a great deal of research has focused on
the mechanism and biological signiﬁcance of this conserved pathway.
Clues regarding how individual steps are regulated have emerged but
much remains unknown. In the present study, we provide evidence
that Argonaute proteins in the most rudimentary RNAi systems are
regulated by the Hsp90 chaperone system. This is consistent with
the growing body of evidence suggesting that a signiﬁcant conforma-
tional change must occur in Argonaute proteins to accommodate
dsRNAs [33–35]. Hsp90 is known to regulate similar conformational
changes in steroid hormone receptors that allow for ligand binding
[36]. While it is possible Hsp90 regulates the S. castellii Dicer that is
common in both reconstituted systems, this seems unlikely in light
of the studies on the Drosophila RNAi system [23,24]. Speciﬁcally,
these reports show that blocking Hsp90 activity does not affectNo RNAi components 
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strains; yeast lacking both the pRS406-PADH1GFP(S65T) reporter construct and the pRS403
yeast harboring both the reporter and silencing constructs. Each strain was grown on media
(centre left), media lacking uracil with DMSO control (centre right), and media lacking ura
then diluted to 1 × 108 cells per ml. 10-fold serial dilutions were prepared and 5μl aliquotsDicer binding to, or processing of, dsRNA precursors but severely im-
pairs Argonaute binding to Dicer products.
We were surprised that human Dicer, even with its cofactor
TRBP2, was not able to reconstitute RNAi in S. cerevisiae with either
S. castellii or human Argonaute given a recent report to the contrary
[21]. The explanation for this discrepancy may lie with the nature of
the silencing constructs we used in our study [19]. Both the strong
and weak silencing constructs we employed are double-stranded;
the weak silencing construct is comprised of two complementary
transcripts and the strong silencing construct is a single transcript
with internal complementarity that results in a double-stranded hair-
pin structure (Fig. 2A–C) [19]. In contrast, the silencing construct
used with human Dicer, Argonaute2 and TRBP2 by Suk and colleagues
is a single-stranded RNA molecule that must anneal directly to the
GFP mRNA to form a double-stranded structure (Fig. 2D) [21]. This
difference could have a profound impact on how RNAi components
are recruited to the dsRNA structure and on how it is processed.
Regardless, it seems that in our assays, human Dicer, TRBP2 and
Argonaute2 are not able to process bona ﬁde RNAi precursors to gen-
erate functional RISC.
Several studies illustrate the importance of the 5′ end and the 3′
overhang structures that result from cleavage of pre-miRNAs by the
microprocessor complex in the nucleus for subsequent processing
by canonical Dicer proteins [7,8,10]. Canonical Dicer proteins bind
to the 3′ overhang generated by microprocessor cleavage via the
PAZ domain. Dicer then acts as a “molecular ruler” and cleaves at a
ﬁxed distance from this PAZ domain via its two RNAseIII domains
and generates the characteristic 21–23 nucleotide dsRNA product.
Importantly, the silencing constructs we used have large portions ofMedia
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complementarity that may not be recognized by the PAZ domain of
humanDicer or, if they are, are too far from the double-stranded portion
of the molecule to result in cleavage. In contrast, non-canonical Dicer
proteins from yeast lack a PAZ domain (Fig. 1) and are thought to
bind to dsRNA substrates as homodimers [37]. Polymerization of these
Dicer homodimers along the length of the dsRNA is thought to facilitate
coordinated cleavage required to generate products 21–23 nt in length
independent of the structure of the substrate ends. This “inside–out”
cleavage mechanismmay allow for the functional versatility associated
with non-canonical Dicer proteins as they are known to play an impor-
tant role in ribosomal and spliceosomal RNA processing [38].
In contrast to Dicer proteins from yeast and humans, Argonaute
proteins are structurally much more conserved. Argonaute proteins
from humans, S. castellii, and the ﬁssion yeast S. pombe share all
four major domains (Fig. 1A). Moreover, two recent publications
[20,35] showed the crystal structures of human and K. polysporus
Argonaute are very similar. Both proteins adopt a bilobed shape
with an internal cleft to bind dsRNA duplexes. Interestingly, the
different domains of Argonaute2 all appear to bind to miRNA in a
fashion that is conserved with other Argonaute homologues [33].
Moreover, Argonaute2 is rendered protease resistant upon miRNA
binding suggesting that the ligand-free protein is less stable and per-
haps more conformationally dynamic that the bound form [33]. This
is important because rapid conformational sampling is one of the
few hallmarks of Hsp90 client proteins. The oncoprotein Bcr–Abl is
a well characterized Hsp90 client protein for which drugs are avail-
able that bind to and stabilize both the active and inactive states
[39]. Intriguingly, stabilization of Bcr–Abl in either conformation
weakens its interaction with Hsp90. Therefore structurally dynamic,
but not necessarily misfolded, proteins are likely to be Hsp90 clients.
Hormone receptors are useful comparisons to Argonaute as an Hsp90
client as well. In the absence of ligand, estrogen and glucocorticoid re-
ceptors form complexes with Hsp90 in the cytoplasm in a ligand-free
state. Hormone binding requires Hsp90 and results in a ligand-bound
but Hsp90-free complex that translocates to the nucleus to activate
downstream transcription [40]. Similar to what is observed with hor-
mone receptors, ligand binding (miRNA in the case or Argonaute) re-
quires Hsp90 and also results in stabilization of the protein.
5. Conclusions
In summary, this study presents a powerful model for studying in-
dividual RNAi components in a minimal system. Furthermore, data
presented here and from other studies [23,24] suggest that Hsp90 is
an evolutionarily conserved regulator of Argonaute proteins, which
may be critical to modulate post-transcriptional gene silencing in re-
sponse to cell stress.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.06.017.
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